Do not stop taking it without talking with your doctor first, as this may have health consequences
GLP-1 and GIP-based therapies may be appropriate for individuals with Type 2 diabetes, insulin resistance, or those who are overweight (BMI 2730+) with at least one weight-related condition such as high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease
This is a low-cost, high-impact intervention that is routinely missed in clinical practice
"Those or large portions of anything really for people who are sensitive to the medications can be problematic," she said
They are available and standing by 24 hours every single day
More concerning are systemic allergic reactions , which affect the body more broadly